Acute leukemia of ambiguous lineage with trisomy 4 as the sole cytogenetic abnormality: A case report and literature review

Leukemia Research Reports

Volumn 3, Issue 2, 2014, Pages 33-35

  Moraveji, S ^a   Torabi, A ^a   Nahleh, Z ^a   Farrag, S ^a   Gaur, S ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

Author keywords

Acute leukemia ambiguous lineage; Biphenotypic leukemia; C Kit; Trisomy 4

Indexed keywords

CD2 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; METHOTREXATE; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; VINCRISTINE;

ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER PREVENTION; CANCER PROGNOSIS; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 4; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE COUNT; MEDICAL HISTORY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THROMBOCYTE COUNT; TREATMENT RESPONSE; TRISOMY; TRISOMY 4;

EID: 84923252988     PISSN: 22130489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lrr.2014.04.003     Document Type: Article

References (12)

1. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H. WHO classification of tumours of the haematopoietic and lymphoid tissues 2008, IARC, Lyon, France. 4th ed.
2. Matutes E., Pickl W.F., Van't Veer M., Morilla R., Swansbury J., Strobl H., et al. Mixed-phenotype acute leukaemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood 2011, 117:3163-3171.
3. Manola K.N. Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview. Br J Haematol 2013, 163:24-39.
4. Bains A., Lu G., Yao H., Luthra R., Medeiros L.J., Sargent R.L. Molecular and clinicopathologic characterization of AML with isolated trisomy 4. Am J Clin Pathol 2012, 137:387-394.
5. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Mitelman F, Johansson B and Mertens F, editors. http://cgap.nci.nih.gov.ezproxy.ttuhsc.edu/Chromosomes/Mitelman.
6. Al-Qurashi F., Owaidah T., Iqbal M.A., Aljurf M. Trisomy 4 as the sole karyotypic abnormality in a case of acute biphenotypic leukemia with T-lineage markers in minimally differentiated acute myelocytic leukemia. Cancer Genet Cytogenet 2004, 150:66-69.
7. Cox-Froncillo M.C., Zollino M., Poeta G.D., Bajer J., Stasi R, Venditti A., et al. Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (MO). Cancer Genet Cytogenet 1995, 80:66-67.
8. Britton V., Kwan Y.L., White L., Yip M.Y. Trisomy 4 in a case of acute biphenotypic leukemia. Cancer Genet Cytogenet 1990, 47:265-269.
9. Keung Y.K., Kaplan B., Douer D. Biphenotypic M0 acute myeloid leukemia with trisomy-4. Leuk Lymphoma 1994, 14:181-184.
10. Ferrari S., Grande A., Zucchini P., Manfredini R., Tagliafico E., Rossi E., et al. Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity. Leuk Lymphoma 1993, 9:495-501.
11. Bains A., Lu G., Yao H., Luthra R., Medeiros L.J., Sargent R.L. Molecular and clinicopathological characterization of AML with isolated trisomy 4. Am J Clin Pathol 2012, 137:387-394.
12. Sandberg A.A., Morgan R., Sait S.N., Berger R, Flandrin G, Schrier S, et al. Trisomy 4: an entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987, 26:117-125.